Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by I. Agirrezabal
Pcn103 - Predicted Treatment Costs and Savings Per Patient of Kanjinti® (Trastuzumab Biosimilar) vs. Subcutaneous (Sc) and Intravenous (Iv) Herceptin® and Other Trastuzumab Biosimilars in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin®)
BioDrugs
Medicine
Biotechnology
Pharmacology
Pharmacoeconomic Study of Herceptin® (Trastuzumab) for Breast Cancer Patients
Pharmacoeconomics: theory and practice
Safety of Trastuzumab (Herceptin®) During Pregnancy: Two Case Reports
Cases Journal
Subcutaneous Administration of Rituximab (MabThera) and Trastuzumab (Herceptin) Using Hyaluronidase
British Journal of Cancer
Cancer Research
Oncology
Trastuzumab (Herceptin)
American Journal of Neuroradiology
Medicine
Nuclear Medicine
Neurology
Imaging
Radiology
Demonstrating Analytical Similarity of Trastuzumab Biosimilar HLX02 to Herceptin® With a Panel of Sensitive and Orthogonal Methods Including a Novel FcγRIIIa Affinity Chromatography Technology
BioDrugs
Medicine
Biotechnology
Pharmacology
Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer
JAMA Oncology
Cancer Research
Oncology
Trastuzumab Biosimilar on Track for Approval
Cancer Discovery
Oncology
Development of HER2-specific Humanized Antibody Herceptin (Trastuzumab).
Folia Pharmacologica Japonica
Pharmacology
